Symbotic Inc. (Nasdaq: SYM) announced its financial results for the fourth quarter and fiscal year 2025.
Revenue for the fourth quarter reached $618 million with a net loss of $19 million and adjusted EBITDA of $49 million.
Cash and cash equivalents increased by $467 million from the prior quarter, totaling $1,245 million at the end of fiscal year 2025.
Revenue Growth
Revenue for fiscal year 2025 was $2,247 million, reflecting a 26% growth year-over-year.
Strategic Expansion
Symbotic added Medline as its first customer in the healthcare vertical, enhancing its value proposition.
Financial Outlook
The company anticipates revenue of $610-630 million for the first quarter of fiscal year 2026.
- Symbotic achieved strong top-line growth and margin expansion in fiscal year 2025, positioning itself for continued success in the industry.
- The company's entrance into the healthcare vertical with Medline marks a strategic move to diversify its customer base and drive future growth.
Symbotic's performance in fiscal year 2025 demonstrates its commitment to growth and innovation, setting a positive trajectory for the upcoming fiscal year.